Oncology Institute Price to Free Cash Flow Ratio 2020-2025 | TOI
Historical price to free cash flow ratio values for Oncology Institute (TOI) since 2020.
| Oncology Institute Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-12-05 | 3.03 | 0.00 | |
| 2025-09-30 | 3.49 | $-0.28 | 0.00 |
| 2025-06-30 | 2.05 | $-0.13 | 0.00 |
| 2025-03-31 | 1.14 | $-0.25 | 0.00 |
| 2024-12-31 | 0.31 | $-0.40 | 0.00 |
| 2024-09-30 | 0.33 | $-0.50 | 0.00 |
| 2024-06-30 | 0.46 | $-0.65 | 0.00 |
| 2024-03-31 | 1.58 | $-0.54 | 0.00 |
| 2023-12-31 | 2.04 | $-0.55 | 0.00 |
| 2023-09-30 | 1.40 | $-0.68 | 0.00 |
| 2023-06-30 | 0.55 | $-0.79 | 0.00 |
| 2023-03-31 | 0.68 | $-0.83 | 0.00 |
| 2022-12-31 | 1.65 | $-0.83 | 0.00 |
| 2022-09-30 | 4.63 | $-1.01 | 0.00 |
| 2022-06-30 | 5.06 | $-0.83 | 0.00 |
| 2022-03-31 | 7.13 | $-0.77 | 0.00 |
| 2021-12-31 | 9.75 | $-0.54 | 0.00 |
| 2021-09-30 | 9.94 | $-0.10 | 0.00 |
| 2021-06-30 | 9.95 | $-0.05 | 0.00 |
| 2021-03-31 | 9.96 | $-0.01 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.298B | $0.393B |
| The Oncology Institute is involved in providing value-based oncology care. The Oncology Institute, formerly known as DFP Healthcare Acquisitions Corp., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $159.812B | 29.35 |
| HCA Healthcare (HCA) | United States | $111.062B | 18.39 |
| CVS Health (CVS) | United States | $96.007B | 11.04 |
| Elevance Health (ELV) | United States | $73.506B | 10.78 |
| Cencora (COR) | United States | $65.892B | 21.24 |
| Natera (NTRA) | United States | $33.751B | 0.00 |
| DiDi Global (DIDIY) | China | $24.867B | 20.32 |
| Labcorp Holdings (LH) | United States | $21.421B | 16.33 |
| Medpace Holdings (MEDP) | United States | $15.439B | 38.33 |
| ICON (ICLR) | Ireland | $15.010B | 14.89 |
| BioMerieux (BMXMF) | France | $14.822B | 0.00 |
| Solventum (SOLV) | United States | $14.818B | 14.38 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.851B | 0.00 |
| Viatris (VTRS) | United States | $12.589B | 4.69 |
| CochLear (CHEOY) | Australia | $11.653B | 0.00 |
| Revvity (RVTY) | United States | $11.427B | 21.04 |
| Charles River Laboratories (CRL) | United States | $9.071B | 17.47 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.143B | 0.00 |
| HealthEquity (HQY) | United States | $8.075B | 30.19 |
| Sonic Healthcare (SKHHY) | Australia | $7.567B | 0.00 |
| Avantor (AVTR) | United States | $7.452B | 11.39 |
| BrightSpring Health Services (BTSG) | United States | $6.455B | 38.48 |
| Bausch + Lomb (BLCO) | Canada | $5.958B | 39.12 |
| PACS (PACS) | United States | $4.817B | 29.30 |
| Sotera Health (SHC) | United States | $4.759B | 22.95 |
| GeneDx Holdings (WGS) | United States | $4.595B | 80.69 |
| Alignment Healthcare (ALHC) | United States | $3.912B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.508B | 20.47 |
| Concentras Parent (CON) | United States | $2.495B | 15.58 |
| Surgery Partners (SGRY) | United States | $2.223B | 28.65 |
| Progyny (PGNY) | United States | $2.071B | 40.71 |
| Establishment Labs Holdings (ESTA) | United States | $2.055B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.900B | 11.34 |
| Organon (OGN) | United States | $1.856B | 1.96 |
| Teladoc Health (TDOC) | United States | $1.347B | 0.00 |
| Ardent Health (ARDT) | United States | $1.259B | 4.11 |
| Nutex Health (NUTX) | United States | $1.138B | 8.70 |
| Omada Health (OMDA) | $1.013B | 0.00 | |
| CareDx (CDNA) | United States | $0.953B | 15.57 |
| GoodRx Holdings (GDRX) | United States | $0.920B | 15.06 |
| Embecta (EMBC) | United States | $0.684B | 3.94 |
| InnovAge Holding (INNV) | United States | $0.682B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.625B | 8.60 |
| Sonida Senior Living (SNDA) | United States | $0.578B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.559B | 0.00 |
| Pomdoctor - (POM) | China | $0.552B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.478B | 0.00 |
| Enhabit (EHAB) | United States | $0.472B | 21.20 |
| SBC Medicals (SBC) | United States | $0.385B | 7.08 |
| Strata Critical Medical (SRTA) | United States | $0.376B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.368B | 5.92 |
| QDM (QDMI) | Hong Kong, SAR China | $0.323B | 67.42 |
| So-Young (SY) | China | $0.315B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.313B | 0.00 |
| Agilon Health (AGL) | United States | $0.270B | 0.00 |
| KindlyMD (NAKA) | United States | $0.224B | 0.00 |
| Beauty Health (SKIN) | United States | $0.186B | 0.00 |
| LifeMD (LFMD) | United States | $0.168B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.127B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.119B | 0.00 |
| DocGo (DCGO) | United States | $0.103B | 0.00 |
| Biodesix (BDSX) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 6.33 |
| Basel Medical Group (BMGL) | Singapore | $0.020B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |